ID
45582
Beschreibung
Principal Investigator: Charles Perou, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,Chapel Hill, NC, USA MeSH: Breast Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000676 The goal of this study is to study gene expression patterns in tumors, normal tissues, and cell lines.
Link
Stichworte
Versionen (1)
- 25.01.23 25.01.23 - Chiara Middel
Rechteinhaber
Charles Perou, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,Chapel Hill, NC, USA
Hochgeladen am
25. Januar 2023
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs000676 Sequence-Based Analysis of Human Breast Tumors
Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, sample ID, and sample use variable of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, age, race, survival event, tumor characteristics including ER, PR, HER2 status, and PAM50 subtype, tumor size, grade, M stage, and nodule status of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID and GEO accession ID of samples obtained from participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID, analyte type, body site where sample was obtained, protocols to extract total RNA, cell or tissue type of sample, tumor status of sample, protocols to remove rRNA from sequencing library, primary tumor, metastasis, or transformed cell line, primary tumor location, sequencing center, tissue type to extract total RNA for library construction, tumor grade, tumor stage, and tumor treatment of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
Ähnliche Modelle
Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, sample ID, and sample use variable of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, age, race, survival event, tumor characteristics including ER, PR, HER2 status, and PAM50 subtype, tumor size, grade, M stage, and nodule status of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID and GEO accession ID of samples obtained from participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID, analyte type, body site where sample was obtained, protocols to extract total RNA, cell or tissue type of sample, tumor status of sample, protocols to remove rRNA from sequencing library, primary tumor, metastasis, or transformed cell line, primary tumor location, sequencing center, tissue type to extract total RNA for library construction, tumor grade, tumor stage, and tumor treatment of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
C0441833 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])